These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8112735)

  • 1. Expression of four mutant human ornithine transcarbamylase genes in cultured Cos 1 cells relates to clinical phenotypes.
    Matsuura T; Hoshide R; Setoyama C; Komaki S; Kiwaki K; Endo F; Nishikawa S; Matsuda I
    Hum Genet; 1994 Feb; 93(2):129-34. PubMed ID: 8112735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of two mutant human ornithine transcarbamylases in COS-7 cells.
    Kogo T; Satoh Y; Kanazawa M; Yamamoto S; Takayanagi M; Ohtake A; Mori M; Niimi H
    J Hum Genet; 1998; 43(1):54-8. PubMed ID: 9609999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.
    Lee JT; Nussbaum RL
    J Clin Invest; 1989 Dec; 84(6):1762-6. PubMed ID: 2556444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
    Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
    Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.
    Matsuura T; Hoshide R; Kiwaki K; Komaki S; Koike E; Endo F; Oyanagi K; Suzuki Y; Kato I; Ishikawa K
    Hum Mutat; 1994; 3(4):402-6. PubMed ID: 8081398
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.
    Matsuda I; Matsuura T; Nishiyori A; Komaki S; Hoshide R; Matsumoto T; Funakoshi M; Kiwaki K; Endo F; Hata A; Shimadzu M; Yoshino M
    J Med Genet; 1996 Aug; 33(8):645-8. PubMed ID: 8863155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel mutations in the human ornithine transcarbamylase (OTC) gene of Korean patients with OTC deficiency and transient expression of the mutant proteins in vitro.
    Kim GH; Choi JH; Lee HH; Park S; Kim SS; Yoo HW
    Hum Mutat; 2006 Nov; 27(11):1159. PubMed ID: 17041896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency.
    Tsai MY; Holzknecht RA; Tuchman M
    Hum Genet; 1993 May; 91(4):321-5. PubMed ID: 8099056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of ornithine transcarbamylase deficiency lacking enzyme protein.
    Saheki T; Imamura Y; Inoue I; Miura S; Mori M; Ohtake A; Tatibana M; Katsumata N; Ohno T
    J Inherit Metab Dis; 1984; 7(1):2-8. PubMed ID: 6429436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal gonadal mosaicism causing ornithine transcarbamylase deficiency.
    Bowling F; McGown I; McGill J; Cowley D; Tuchman M
    Am J Med Genet; 1999 Aug; 85(5):452-4. PubMed ID: 10405441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.
    Ye X; Zimmer KP; Brown R; Pabin C; Batshaw ML; Wilson JM; Robinson MB
    Hum Gene Ther; 2001 Jun; 12(9):1035-46. PubMed ID: 11399226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
    Climent C; Rubio V
    Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism.
    Tuchman M; Holzknecht RA; Gueron AB; Berry SA; Tsai MY
    Pediatr Res; 1992 Nov; 32(5):600-4. PubMed ID: 1480464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
    Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
    J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine transcarbamylase (OTC) deficiency in a female patient with a de nova deletion of the paternal X chromosome.
    Slomski R; Braulke I; Behrend C; Schröder E; Colombo JP; Reiss J
    Hum Genet; 1992 Aug; 89(6):632-4. PubMed ID: 1511981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.
    García-Pérez MA; Climent C; Briones P; Vilaseca MA; Rodés M; Rubio V
    J Inherit Metab Dis; 1997 Nov; 20(6):769-77. PubMed ID: 9427144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved molecular diagnostics for ornithine transcarbamylase deficiency.
    Grompe M; Caskey CT; Fenwick RG
    Am J Hum Genet; 1991 Feb; 48(2):212-22. PubMed ID: 1671317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.